Fabrication and application of targeted ciprofloxacin nanocarriers for the treatment of chronic bacterial prostatitis

• Autores principales: Sahar I. Mohammad (Autor), Basmah Nasser Aldosari (Autor), Magda M. Mehanni (Autor), Ahmed O. El-Gendy (Autor), Walaa G. Hozayen (Autor), Obaid Afzal (Autor), Randa Mohammed Zaki (Autor), Ossama M. Sayed (Autor)
• Formato: Libro
• Publicado: Elsevier, 2024-06-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Pathogenic bacteria cause chronic bacterial prostatitis (CBP). CPB is characterized by urinary tract infection and persistence of pathogenic bacteria in prostatic secretion. Owing to poor blood supply to the prostate gland and limited drug penetration, CBP treatment is difficult. Transferosomes are...